Adolescent polycystic ovary syndrome according to the international evidence-based guideline.
Level 5 - mechanism / opinion, no new human data
Clinical practice guideline summary and expert consensus based on systematic reviews
PubMed 32204714 · doi:10.1186/s12916-020-01516-x
What was done
An international panel of healthcare professionals, evidence synthesis teams, and consumers developed clinical recommendations for adolescent polycystic ovary syndrome (PCOS) using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework to appraise evidence quality, feasibility, acceptability, cost, and implementation.
What was found
The guideline establishes specific diagnostic criteria to prevent overdiagnosis: (1) menstrual irregularity defined by post-menarche timing—cycles >90 days (>1 year post-menarche), <21 or >45 days (1–3 years post-menarche), <21 or >35 days (>3 years post-menarche), or primary amenorrhea by age 15 or >3 years post-thelarche (irregularity <1 year post-menarche is considered normal development); (2) clinical (hirsutism, severe acne) or biochemical hyperandrogenism; (3) exclusion of pelvic ultrasound within 8 years post-menarche; (4) exclusion of anti-Müllerian hormone (AMH) testing; and (5) ruling out mimicking disorders. Adolescents with partial features should be categorized as 'at risk' and reassessed. Routine screening for anxiety, depression, and eating disorders is recommended, alongside lifestyle interventions, combined oral contraceptives, and/or metformin for symptom management.
Why it matters
Normal pubertal development frequently mimics adult PCOS criteria, leading to widespread misdiagnosis and unnecessary treatment. These clear post-menarche chronological cutoffs and restrictions on ultrasound and AMH establish distinct pediatric standards to avoid overdiagnosis.
Limits
The abstract does not provide the underlying search strategy, the number of primary studies reviewed, or specific quantitative effect sizes and GRADE confidence ratings for each therapeutic recommendation.
Cited by
- supports Ovarian morphology on ultrasound and AMH levels should not be used as diagnostic criteria for PCOS in teenagers.